procarbazine has been researched along with Alloxan Diabetes in 3 studies
Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hyperglycemia has been linked to increased oxidative stress, leading to endothelial dysfunction, delayed cell replication, and enhanced apoptosis." | 1.32 | Heme oxygenase-1 prevents superoxide anion-associated endothelial cell sloughing in diabetic rats. ( Abraham, NG; Goodman, AI; Ikehara, S; Inaba, M; Kaminski, PM; Morita, T; Quan, S; Wolin, MS; Yang, L, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Quan, S | 1 |
| Kaminski, PM | 1 |
| Yang, L | 1 |
| Morita, T | 1 |
| Inaba, M | 1 |
| Ikehara, S | 1 |
| Goodman, AI | 1 |
| Wolin, MS | 1 |
| Abraham, NG | 1 |
| Mullen, Y | 2 |
3 other studies available for procarbazine and Alloxan Diabetes
| Article | Year |
|---|---|
Heme oxygenase-1 prevents superoxide anion-associated endothelial cell sloughing in diabetic rats.
Topics: Animals; Anions; Antineoplastic Combined Chemotherapy Protocols; Aorta; Apoptosis; Bilirubin; Blotti | 2004 |
Specific immunosuppression for fetal pancreas allografts in rats.
Topics: Animals; Diabetes Mellitus, Experimental; Fetus; Glucose Tolerance Test; Graft Survival; Histocompat | 1980 |
Permanent reversal of experimental diabetes in rats by allogeneic fetal pancreases across minor histocompatibility loci: effects and characteristics of immunosuppression induced by alloantigen, PCH, and ALS treatment.
Topics: Animals; Antilymphocyte Serum; Diabetes Mellitus, Experimental; Female; Fetus; Graft Survival; Histo | 1981 |